Biosimilars are essential for sustainable healthcare systems across Europe; however, key challenges remain as seen with biosimilars for long-acting insulin analogues

Autor: Godman, Brian, Tubić, Biljana, Allocati, Eleonora, Wladysiuk, Magdalene, McTaggart, Stuart, Kurdi, Amanj, Haque, Mainul, MacBride-Stewart, Sean, Kalemeera, Francis, Massele, Amos, Hoxha, Iris, Marković-Peković, Vanda, Petrova, Guenka, Tachkov, Konstantin, Laius, Ott, Harsanyi, András, Inotai, Andras, Jakupi, Arianit, Henkuzens, Svens, Garuolienė, Kristina, Vella Bonanno, Patricia, Rutkowski, Jakub, Mardare, Ileana, Fürst, Jurij, Pontes, Caridad, Zara, Corinne, Turu Pedrola, Marta, Akter, Farhana, Kwon, Hye-Young, Martin, Antony P, Banzi, Rita, Wale, Janney, Gulbinovic, Jolanta

Sales of medicines continue to grow world-wide driven in part by increasing expenditures on biological medicines leading to concerns with the long-term sustainability of European healthcare systems. The increasing use of biosimilars at lower costs ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::05f29315047e3ce7578169fb7eb3bf69
https://strathprints.strath.ac.uk/79311/7/Godman_etal_JAPS_2022_Biosimilars_are_essential_for_sustainable_healthcare_systems_across.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".

Autor: Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Wladysiuk M; Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland.; HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland., McTaggart S; Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK., Kurdi A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq., Allocati E; Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy., Jakovljevic M; Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.; Institute of Comparative Economic Studies, Hosei University Tokyo, Japan.; Department of Global Health Economics and Policy, University of Kragujevac, Serbia., Kalemeera F; Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia., Hoxha I; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania., Nachtnebel A; Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria., Sauermann R; Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria., Hinteregger M; Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria., Marković-Peković V; Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina., Tubic B; Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.; Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina., Petrova G; Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria., Tachkov K; Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria., Slabý J; State Institute for Drug Control, Prague, Czech Republic., Nejezchlebova R; State Institute for Drug Control, Prague, Czech Republic., Krulichová IS; Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic., Laius O; State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia., Selke G; Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany., Langner I; Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany., Harsanyi A; Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary., Inotai A; Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary., Jakupi A; Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo., Henkuzens S; Independent Consultant, Riga, Latvia., Garuolienė K; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Gulbinovič J; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Bonanno PV; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.; Department of Health Services Management, University of Malta, Valletta, Malta., Rutkowski J; HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland., Ingeberg S; Medicines Committee, Oslo University Hospitals, Oslo, Norway., Melien Ø; Medicines Committee, Oslo University Hospitals, Oslo, Norway., Mardare I; Faculty of Medicine, Public Health and Management Department, 'Carol Davila' University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania., Fürst J; Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia., MacBride-Stewart S; Pharmacy Services, Greater Glasgow and Clyde (NHS GGC), Glasgow, UK., Holmes C; NHS Lothian, Edinburgh, UK., Pontes C; Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Zara C; Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain., Pedrola MT; Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain., Hoffmann M; NEPI-Nätverk för Läkemedelsepidemiologi, Stockholm, Sweden., Kourafalos V; National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece., Pisana A; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., Banzi R; Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy., Campbell S; Centre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK., Wettermark B; Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Uppsala, Sweden.

Publikováno v: BioMed research international [Biomed Res Int] 2023 Apr 07; Vol. 2023, pp. 9757348. Date of Electronic Publication: 2023 Apr 07 (Print Publication: 2023).